Entheon Biomedical Corp. (ENTBF)
OTCMKTS · Delayed Price · Currency is USD
0.0720
-0.0080 (-10.00%)
Jul 14, 2025, 4:00 PM EDT

Entheon Biomedical Ratios and Metrics

Millions USD. Fiscal year is Dec - Nov.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Jul '25 Nov '24 Nov '23 Nov '22 Nov '21 Nov '20 2019
11012524
Upgrade
Market Cap Growth
495.57%103.34%-66.76%-94.74%5.41%-
Upgrade
Enterprise Value
11012222
Upgrade
Last Close Price
0.070.100.080.264.015.90
Upgrade
PS Ratio
--2.369.35--
Upgrade
PB Ratio
2.928.531.872.883.528.20
Upgrade
P/TBV Ratio
2.928.531.872.8810.138.20
Upgrade
EV/Sales Ratio
--0.848.04--
Upgrade
Asset Turnover
--0.430.04--
Upgrade
Quick Ratio
8.373.544.114.672.244.00
Upgrade
Current Ratio
8.804.534.644.813.466.05
Upgrade
Return on Equity (ROE)
-104.96%-137.90%-64.49%-42.66%-125.03%-231.39%
Upgrade
Return on Assets (ROA)
-59.05%-70.93%-33.41%-41.88%-71.06%-44.49%
Upgrade
Return on Capital (ROIC)
-68.18%-90.19%-42.03%-46.57%-80.25%-54.11%
Upgrade
Earnings Yield
-26.60%-25.63%-50.77%-480.67%-27.87%-14.27%
Upgrade
FCF Yield
--28.68%-60.91%-110.26%-16.72%-9.27%
Upgrade
Buyback Yield / Dilution
-56.84%-30.96%--8.85%-97.83%-543.78%
Upgrade
Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.